NIH-funded research NIH-funded research

Understanding how proteins change cell types

Official title: Transcription Factors Overcoming Chromatin Barriers to Control Cell Fate

Funded at University of Pennsylvania · NIH-11046607 · Data updated 2026-11-12

This study is looking at how certain proteins can help change the way cells behave, which could lead to new ways to create different types of cells for treatments and understanding diseases better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$608,540
NIH project number5R35GM153180-02
Project IDNIH-11046607 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that could benefit from cell-based therapies, such as degenerative diseases or injuries requiring tissue regeneration.

Less likely to help

Patients with conditions that do not involve cell differentiation or reprogramming may not receive benefits from this research.

What this research studies

This research investigates how specific proteins, known as transcription factors, can overcome structural barriers in chromosomes to change the fate of cells. By studying the interactions between these factors and chromatin, the research aims to uncover new methods for generating different cell types that could be used in therapies and disease modeling. The approach combines various techniques, including biochemical assays and genomic sequencing, to provide insights into gene regulation and cellular reprogramming.

Why it matters

Potential benefit: If successful, this research could lead to more efficient methods for creating new cell types for therapeutic use.

How similar studies have gone: Previous research has shown promising results in understanding transcription factors and their role in cell fate changes, indicating that this approach has potential for success.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Zaret, Kenneth — University of Pennsylvania
  • Study coordinator: Zaret, Kenneth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.